A case of anti-NMDAR encephalitis presented hypotensive shock during plasma exchange.
Brain Dev. 2016 Apr; 38(4):427-30.BD

Abstract

We are reporting on a case of pediatric anti-NMDAR encephalitis with autonomic instability. The patient showed little response to first-line treatment of steroid and IVIG. We initiated plasma exchange, also a first-line treatment. This worsened his autonomic instability, resulting in hypotensive shock. He responded well to rituximab and cyclophosphamide, second-line therapies. Anti-NMDAR encephalitis is often accompanied by autonomic instability. Our and other reported cases, raise the question of plasma exchange as a first-line therapy for pediatric NMDAR encephalitis, which is frequently accompanied by autonomic instability. Plasma exchange should be performed cautiously in such patients.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Miyauchi A
Department of Pediatrics, Jichi Medical University, Japan.
Monden Y
Department of Pediatrics, Jichi Medical University, Japan. Electronic address: mon4441977319@jichi.ac.jp.
Osaka H
Department of Pediatrics, Jichi Medical University, Japan.
Takahashi Y
National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.
Yamagata T
Department of Pediatrics, Jichi Medical University, Japan.

MeSH

Anti-N-Methyl-D-Aspartate Receptor EncephalitisBrainChildCyclophosphamideHumansHypotensionImmunosuppressive AgentsImmunotherapyMalePlasma ExchangePlasmapheresisRituximabShockTreatment Outcome

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

26524986